Researchers from Yale University have discovered a molecular mechanism causing structural abnormalities responsible for lissencephaly, providing a path for potential treatments. Through whole genome sequencing, the research team successfully identified a CRISPR-Cas9 treatment that could both prevent and reverse the effects of the lissencephaly-causing mutations. The team now intends to explore the functions of the mTOR pathway in other genetic forms of lissencephaly.
News – Masimo reports cyber incident affecting production sites – teiss
Masimo has reported a cyber incident that has impacted its production sites. The company is currently assessing the situation to understand the extent of the
